CLSI eNews - 1 October 2005 (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.

News
Executive Vice President's Message
Volunteer Focus
Press Releases
Special Section: The CLSI Consensus Process
Month-by-Month: The Basics
Illustrated: The Timeline
Standards Status
Vote and Deadlines
Call for Nominations
News and Events
Upcoming Events
Upcoming Presentations
Calendar of Events
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Suscription

Vote and Deadlines

Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria (M45-P)

M45-P—Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Proposed Guideline
The M45-P guideline addresses organisms that may cause serious infections, such as infective endocarditis; infections associated with trauma and environmental contamination; or device associated infections in immunocompromised or postsurgical patients, such as intravascular catheters, implanted devices, and CNS shunts. The deadline for the completed ballot for M45-P to be received at the CLSI offices is 2 January 2006.

Second Notice

I/LA27-P—Newborn Screening Follow-up; Proposed Guideline
I/LA27-P describes the basic principles, scope, and range of follow-up activities within the newborn screening system. It is intended for use by those involved in any aspect of follow-up, including healthcare providers, parents, and others concerned with the health and welfare of newborns. The deadline for the completed ballot for I/LA27-P to be received at the CLSI offices is 13 December 2005.

GP2-A5—Laboratory Documents: Development and Control; Approved Guideline—Fifth Edition
This document presents the important components of writing and managing documents for the clinical laboratory, including descriptions of common and specific sections for inclusion. Appendixes provide examples of process and procedure documents for preexamination, examination, and postexamination laboratory activities. The deadline for the completed ballot for GP2-A5 to be received at the CLSI offices is 14 November 2005.

Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the Executive Offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership.